Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stomatin is a highly conserved, 31 kDa monotopic integral membrane protein, primarily found in red blood cells but expressed widely across tissues[1][2][6]. It is a member of the SPFH (Stomatin/Prohibitin/Flotillin/HflK/C) domain family and associates with cholesterol-rich domains (lipid rafts) in the plasma membrane, where it acts as a scaffolding protein regulating the activity of numerous ion channels and transporters, including anion exchanger 1 (AE1) and glucose transporter (GLUT1)[5][7]. Stomatin plays a structural role in organizing membrane architecture, modulating ion transport, and influencing processes such as cell division and membrane fusion[3][5]. Loss of stomatin or its mislocalization is linked to hereditary stomatocytosis, a form of hemolytic anemia characterized by sodium and potassium leakage from red blood cells[1][2][6]. There is currently no direct therapeutic targeting of stomatin, but its deficiency or dysfunction serves as a molecular marker in selected blood and bone disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stomatin (STOM).